CADL
Candel Therapeutics, Inc. Common Stock
BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)
Best Biotech Stocks 2026 →
Candel Therapeutics (CADL) Stock: Buy, Sell, or Hold?
$9.22
-0.13 (-1.39%)
âŧ
5d:
+1.88%
30d:
-0.54%
90d:
-21.86%
QUANTITATIVE VERDICT
WAIT
LOW Confidence (48%)
Quality Score
42/100
Position
SLIGHTLY HIGH
30-Day Fair Range
$8.21 â $9.70
Position: SLIGHTLY HIGH
Forward P/E & Valuation
-14.8x
CHEAP
vs 40.5x historical avg
Wall Street Target
$22.11
+139.8% upside
Options IV & Volume
HIGH Vol
HIGH volume confirmation
Support / Resistance
$7.92 / $9.84
Trend: Downtrend
Executive Thesis & Bottom Line
Forward Earnings Fair Value & Price Prediction →
âšī¸ NEUTRAL: CADL is fairly priced but lacks strong directional signals. At 0% expected growth, valuation appears cheap. Wait for clearer setup or better entry on dips.
Get Alerted When CADL Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
In-depth Analysis How we analyze
Valuation Analysis: CADL is currently trading at $9.22, which is considered slightly high relative to its 30-day fair value range of $8.21 to $9.70. From a valuation perspective, the stock is trading at a discount (Forward PE: -14.8) compared to its historical average (40.5). At these levels, the market is pricing in 0% annual earnings growth. This growth rate appears achievable given the company's track record, suggesting the valuation is rational.
Technical Outlook: Technically, CADL is in a downtrend. Immediate support is located at $7.92, while resistance sits at $9.84.
Market Sentiment: CADL scores 30/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Wall Street analysts see significant upside, with an average price target of $22.11 (+139.8%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, CADL is in a downtrend. Immediate support is located at $7.92, while resistance sits at $9.84.
Market Sentiment: CADL scores 30/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Wall Street analysts see significant upside, with an average price target of $22.11 (+139.8%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
SLIGHTLY HIGH
Historical Trading Range
$8.21 -
$9.70
Company Quality Score
42/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
47.6%
Trading Range & Key Levels
30-Day Trading Range
$8.21 -
$9.70
Current vs Trading Range
SLIGHTLY HIGH
Support Level
$7.92
Resistance Level
$9.84
Current Trend
Downtrend
Technical data as of
Nov 11, 2026
Quantitative Signal Breakdown
- BEARISH: Weak technical setup (30/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 139.8% below Wall St target ($22.11)
- BULLISH: Market expects only 0% annual growth - appears undervalued
- WARNING: Composite score 42/100 in the bottom quintile â this cohort historically lags the market
Fundamental Context
Forward P/E (Next Year Est.)
-14.75
Wall Street Target
$22.11
(+139.8%)
PE vs Historical
-14.8 vs 40.5
CHEAP
Share CADL Analysis
Share this live CADL analysis (with rich preview card) to Reddit, StockTwits, X, or embed the chart on your blog.
bloggers & journalists: you are free to use our charts with attribution.Reddit & Retail Trader Sentiment (CADL)
Bullish
12 Retail Mentions
Reddit / WSB Comments
1
Bearish
StockTwits Volume
11 msgs
24h retail stream
Last Tracked
Nov 12, 2026
Daily AI digest
AI Retail Discussion Summary:
StockTwits is filled with bullish sentiment towards $CADL, with traders discussing its potential in the prostate cancer treatment market, which is the most common cancer diagnosis in men in the US and 118 other countries.
Key Retail Themes:
Prostate cancer market potential
Global reach of the treatment
Aggregated from r/wallstreetbets, r/stocks & StockTwits streams.
View All Trending Reddit & WSB Stocks →
Last updated: November 12, 2026 3:09 AM ET
Data refreshes hourly during market hours. Next update: 4:09 AM
Data refreshes hourly during market hours. Next update: 4:09 AM
đĨ Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is CADL showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
CYTK
Cytokinetics Inc |
STRONG BUY
22 analysts |
$107 | 61 BUY |
|
INSM
Insmed Inc |
STRONG BUY
24 analysts |
$194 | 37 SELL |
|
MDGL
Madrigal PharmaceuticalsâĻ |
STRONG BUY
19 analysts |
$689 | 56 HOLD |
|
CRNX
Crinetics PharmaceuticalâĻ |
STRONG BUY
17 analysts |
$86 | 46 HOLD |
|
RCUS
Arcus Biosciences Inc |
STRONG BUY
15 analysts |
$41 | 63 BUY |
Explore More Analysis & Live Quant Tools
Part A: Deep-Dive CADL Research Pages
